Skip to main content

Table 1 Clinical characteristic of MPP with hypoxia, RMPP and GMPP patients

From: Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children

Clinical information

MPP WITH HYPOXIA(n = 69)

RMPP(n = 86)

GMPP(n = 190)

P-value

Sex (male/female)

34/35

48/38

112/78

0.381

Age, years

6 (4–8)

6 (4–8)

6 (4–7)

0.125

Clinical presentation n(%)

 Fever

69 (100%)

86 (100%)

186 (97.89%)

1.000

    

0.000

  37.5–38 °C

0 (0%)

0 (0%)

10 (5.38%)

 

  38.1–39 °C

6 (8.69%)

20 (23.25%)

53 (28.49%)

 

  39.1–41 °C

61 (88.41%)

64 (74.42%)

122 (65.59%)

 

  >41 °C

2 (2.90%)

2 (2.33%)

1 (0.54%)

 

 Cough

69 (100%)

86 (100%)

190 (100%)

1.000

 Chest pain

18 (26.09%)

3 (3.49%)

2 (1.05%)

0.000

 Rash

10 (14.49%)

3 (3.49%)

14 (7.37%)

0.043

 Thromboembolism

7 (10.14%)

0 (0%)

0 (0%)

0.000

 Wheezing

8 (11.59%)

10 (11.63%)

30 (15.79%)

0.533

 Dyspnea

69 (100%)

2 (2.32%)

0 (0%)

0.000

 Liver function damage

13 (18.84%)

5 (5.81%)

16 (8.42%)

0.023

 Toxic encephalopathy

9 (13.04%)

2 (2.32%)

0 (0%)

0.000

 Mucous plugging

36 (52.17%)

16 (18.60%)

2 (1.05%)

0.000

Length of fever, days

12 (9–14)

10 (8–12)

6 (8–10)

0.000

Length of stay, days

12 (9–15)

9 (8–10)

6 (5–7)

0.000

Management

 Using Azithromycin

69 (100%)

86 (100%)

130 (100%)

1.000

 Using glucocorticoids

69 (100%)

58 (84.06%)

78 (41.05%)

0.000

 Using gamma immunoglobulin

34 (49.27%)

0 (0%)

0 (0%)

0.000

 Using fiberoptic bronchoscope

58 (84.06%)

61 (70.93%)

82 (43.16%)

0.000

 Using oxygen-therapy

69 (100%)

2 (2.32%)

0 (0%)

0.000

  1. Data are presented as number (percentage), median (25th–75th percentile)